BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/8/2019 4:22:31 AM | Browse: 677 | Download: 1048
 |
Received |
|
2019-04-06 07:26 |
 |
Peer-Review Started |
|
2019-04-08 06:37 |
 |
To Make the First Decision |
|
2019-08-02 03:06 |
 |
Return for Revision |
|
2019-08-02 06:20 |
 |
Revised |
|
2019-08-26 08:21 |
 |
Second Decision |
|
2019-08-29 04:15 |
 |
Accepted by Journal Editor-in-Chief |
|
2019-08-29 08:02 |
 |
Accepted by Executive Editor-in-Chief |
|
2019-09-09 08:30 |
 |
Articles in Press |
|
2019-09-09 08:30 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2019-09-21 05:16 |
 |
Publish the Manuscript Online |
|
2019-11-08 04:22 |
ISSN |
2307-8960 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non- commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Medicine, Research & Experimental |
Manuscript Type |
Case Report |
Article Title |
Retroperitoneal perivascular epithelioid cell tumours: A case report and review of literature
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Zisis Touloumis, Niki Giannakou, Christos Sioros, Argyro Trigka, Maria Cheilakea, Nikoletta Dimitriou and John Griniatsos |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Zisis Touloumis, MD, Doctor, Doctor, Surgeon, Department of Surgery, Athens Medical Group, 10th Douna str, Athens 115 25, Greece. ztouloumis@gmail.com |
Key Words |
Perivascular epithelioid cell tumour; Retroperitoneum; Mammalian target of the rapamycin inhibitors; Tuberous sclerosis complex; Case report; Treatment |
Core Tip |
The retroperitoneal space represents the third most frequent location for perivascular epithelioid cell tumours (PEComas) not otherwise specified development. Half were stratified as potentially malignant, and nearly half of the potentially malignant tumours presented with or developed metastases during the course of the disease. Thus, retroperitoneal PEComas are not as indolent as they are supposed to be. Radical surgical resection constitutes the treatment of choice for localized disease, while mammalian target of the rapamycin (mTOR) inhibitors constitute the most promising therapy for disseminated disease. The role of mTOR inhibitors as adjuvant or neoadjuvant therapies needs to be evaluated in the future. |
Publish Date |
2019-11-08 04:22 |
Citation |
Touloumis Z, Giannakou N, Sioros C, Trigka A, Cheilakea M, Dimitriou N, Griniatsos J. Retroperitoneal perivascular epithelioid cell tumours: A case report and review of literature. World J Clin Cases 2019; 7(21):3524-3534 |
URL |
https://www.wjgnet.com/2307-8960/full/v7/i21/3524.htm |
DOI |
https://dx.doi.org/10.12998/wjcc.v7.i21.3524 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345